Tag: drug safety monitoring
FDA Black Box Warnings on Antidepressants for Youth: Risks and Real-World Impact
The FDA's Black Box Warning on antidepressants for youth, issued in 2005, aimed to reduce suicide risk. However, studies show it led to fewer prescriptions and increased suicide attempts. Experts now question its effectiveness, with calls for reevaluation. Real-world data reveals unintended consequences outweighing intended benefits.
Read More
15 Comments
